Pharmaceuticals News and Research

RSS

Enzon first quarter adjusted loss from continuing operations decreases to $4.2 million

Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2011.

7 May 2011

Spherix effects 1-for-10 reverse stock split

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it has filed a Certificate of Amendment to its Certificate of Incorporation, as amended, to effect a 1-for-10 reverse stock split of its common stock that will become effective at end of business today.

7 May 2011

Researchers find temperature-sensing protein in immune cells

Researchers at The Scripps Research Institute have found a temperature-sensing protein within immune cells that, when tripped, allows calcium to pour in and activate an immune response.

7 May 2011

Spotlight on the NDM-1 “superbug” highlights the long-standing but increasingly alarming situation of antibiotic resistance globally

At the world’s largest conference on infectious diseases – the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) which opens today – a special Symposium on NMD-1 (New Delhi metallo-beta-lactamase) will focus on the implications of the increasing detection of this gene, which makes bacteria highly resistant to almost all known antibiotics. This is part of an alarming trend of antibiotic resistance that threatens to turn back the clock on years of progress following the discovery of antimicrobials, which revolutionised human health globally.

6 May 2011

AGA honors four young gastroenterologists with prestigious Research Scholar Awards

The American Gastroenterological Association Research Foundation has announced its 2011 research scholars. The grants have been awarded to four outstanding young gastroenterologists who promise to make significant strides in the field of gastrointestinal research.

6 May 2011

SAS Health Care & Life Sciences Executive Conference to discuss clinical research best practices

Drug developers are challenged as never before to deliver innovative medicines through a business model that boosts the bottom line. Optimizing clinical trial design and portfolio management is paramount for managing outcomes and costs, and for rapidly advancing new drugs to the marketplace.

6 May 2011

Patent expiries, generic pricing policies may be factors in slow drug spending growth

Although drugs remain an important cost driver in Canada's health system, growth in spending has slowed to its lowest rate in 14 years, according to a new report released today by the Canadian Institute for Health Information.

6 May 2011

Pacira to present EXPAREL data in postsurgical pain at two medical meetings

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that clinical and preclinical data highlighting the safety and efficacy of EXPAREL™ will be presented at two medical meetings.

6 May 2011

Omeros' PDE7 program expands addiction franchise

Omeros Corporation today announced that its phosphodiesterase 7 inhibitors demonstrated robust efficacy in animal models of nicotine addiction.

6 May 2011

MMRF, APGD collaborate to develop OSI-906 for relapsed multiple myeloma treatment

The Multiple Myeloma Research Foundation and Astellas Pharma Global Development, Inc. today announced that they have entered into a joint collaboration for the clinical development of OSI-906 in patients with relapsed multiple myeloma.

6 May 2011

Savings projected from 'emerging' generic drugs

But the Federal Trade Commission found an "unprecedented" increase in drug industry deals to delay the availability of these cheaper drugs.

6 May 2011

Furiex Pharmaceuticals to present two JNJ-Q2 antibiotic abstracts at ECCMID/ ICC congress

Furiex Pharmaceuticals, Inc. today announced that two abstracts featuring its antibiotic candidate JNJ-Q2 will be presented at the 2011 joint meeting of the European Congress of Clinical Microbiology and Infectious Diseases and the International Congress of Chemotherapy.

6 May 2011

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration approved Afinitor tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin in patients with unresectable, locally advanced or metastatic disease.

6 May 2011

COIN hosts nanobiotechnology event on nanomedicines and the regulatory path

The Center of Innovation for Nanobiotechnology (COIN) today announced the upcoming NanoBio Executive Roundtable event to be hosted at RTP Foundation in Durham, NC on May 17, 2011. This Roundtable will tackle regulatory issues surrounding nanomedicine commercialization. The “Nanomedicines and the Regulatory Path” Roundtable will kick off with a presentation from Katherine Tyner, Ph.D., a Chemist in the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA).

5 May 2011

$Bone building drugs bisphosphonates lead to only a marginally higher risk of fractures: Study$

Bone building drugs bisphosphonates lead to only a marginally higher risk of fractures: Study

According to a new study, nearly 78% of all Swedish women aged 55 years and older who sustained a thigh bone or femur fracture in 2008 had taken bisphosphonates for their osteoporosis. However the authors of the study published in the May 5 issue of the New England Journal of Medicine (NEJM) write that the absolute risk for such breaks is small enough to justify prescribing the drugs.

5 May 2011

Asthma ‘pill-a-day’ shows similar effectiveness as inhalers: Study

A new study has shown that a ‘once-a-day’ pill may be on par with an inhaler at combating asthma. This tablet, say researchers could revolutionize treatment for the condition, meaning patients are no longer reliant on inhalers, which many find difficult to use. Around 5.4 million Britons have asthma, including 1.1 million children.

5 May 2011